SCHEMBL30763286

SCHEMBL30763286

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ PTH1R Q03431 8/20 0.52
▸ CALCR P30988 3/20 0.50
▸ CRHR1 P34998 1/20 0.50
▸ CRHR2 Q13324 1/20 0.50
▸ KEAP1 Q14145 1/20 0.47
▸ GLP1R P43220 2/20 0.47
▸ BACE1 P56817 1/20 0.47
▸ F2 P00734 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30136427 0.94 PTH1R (0.55) PTH1RCALCRCRHR1CRHR2GLP1R
SCHEMBL29407403 0.91 PTH1R (0.59) PTH1RCALCRCRHR1CRHR2GLP1R
SCHEMBL31303964 0.91 PTH1R (0.59) PTH1RCALCRCRHR1CRHR2GLP1R
SCHEMBL30136490 0.91 PTH1R (0.59) PTH1RCALCRCRHR1CRHR2GLP1R
SCHEMBL31307253 0.89 CRHR1 (0.49) PTH1RCALCRCRHR1CRHR2KEAP1
SCHEMBL29805149 0.89 CALCR (0.48) CALCRCRHR1CRHR2KEAP1GLP1R
SCHEMBL30449532 0.88 PTH1R (0.65) PTH1RCALCRGLP1RRXFP1
SCHEMBL30262081 0.86 CALCR (0.59) CALCRCRHR1CRHR2KEAP1GLP1R
SCHEMBL30436811 0.85 GLP1R (0.56) CALCRCRHR1CRHR2GLP1RF2
SCHEMBL31656529 0.84 CALCR (0.62) CALCRCRHR1CRHR2GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117586372-A Long-acting teriparatide compound 成都奥达生物科技有限公司 2024-02-23 — — CN claimed
CN-117586372-A Long-acting teriparatide compound 成都奥达生物科技有限公司 2024-02-23 — — CN disclosed
Send feedback